Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Immediate Implant Placement in a Patient With Osteoporosis Undergoing Bisphosphonate Therapy: 1-Year Preliminary Prospective Study.

Siebert T, Jurkovic R, Statelova D, Strecha J.

J Oral Implantol. 2015 Jul;41 Spec No:360-5. doi: 10.1563/AAID-JOI-D-13-00063.

PMID:
24041299
2.

Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.

Fitzpatrick SG, Stavropoulos MF, Bowers LM, Neuman AN, Hinkson DW, Green JG, Bhattacharyya I, Cohen DM.

J Oral Maxillofac Surg. 2012 Feb;70(2):325-30. doi: 10.1016/j.joms.2011.02.049. No abstract available.

PMID:
21723015
3.
4.

Implant Placement Adjacent to Successfully Treated Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).

Rugani P, Kirnbauer B, Acham S, Truschnegg A, Jakse N.

J Oral Implantol. 2015 Jul;41 Spec No:377-81. doi: 10.1563/AAID-JOI-D-13-00178. No abstract available.

PMID:
24593250
5.

Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study.

Famili P, Quigley S, Mosher T.

Compend Contin Educ Dent. 2011 Jul-Aug;32(6):E106-9.

PMID:
23738968
6.

Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.

Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, Meier C.

Clin Drug Investig. 2013 Feb;33(2):117-22. doi: 10.1007/s40261-012-0041-1.

PMID:
23184667
7.

Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.

Woodis CB.

Ann Pharmacother. 2008 Jul;42(7):1085-9. doi: 10.1345/aph.1K652.

PMID:
18505912
8.

Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw.

Abtahi J, Agholme F, Sandberg O, Aspenberg P.

J Dent Res. 2013 Mar;92(3):279-83. doi: 10.1177/0022034512472335.

PMID:
23264610
10.

Implant placement in patients with oral bisphosphonate therapy: a case series.

Shabestari GO, Shayesteh YS, Khojasteh A, Alikhasi M, Moslemi N, Aminian A, Masaeli R, Eslami B, Treister NS.

Clin Implant Dent Relat Res. 2010 Sep;12(3):175-80. doi: 10.1111/j.1708-8208.2009.00150.x.

PMID:
19438964
11.

Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.

Grant BT, Amenedo C, Freeman K, Kraut RA.

J Oral Maxillofac Surg. 2008 Feb;66(2):223-30. doi: 10.1016/j.joms.2007.09.019.

PMID:
18201600
12.

[Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project].

Dalle Carbonare L, Bertoldo F, Lo Cascio V.

Reumatismo. 2009 Jan-Mar;61(1):54-64. Italian.

13.

Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (Reclast): report of 4 cases.

Lee CY, Suzuki JB.

Implant Dent. 2015 Apr;24(2):227-31. doi: 10.1097/ID.0000000000000227.

PMID:
25734948
14.

Osteonecrosis related to once-yearly zoledronic acid treatment in an osteoporotic patient after dental implant.

Miniello TG, Araújo JP, Lopes RN, Alves FA.

Braz Dent J. 2015 Jan-Feb;26(1):86-8. doi: 10.1590/0103-6440201300255.

15.
16.
17.

Immediate versus nonimmediate placement of implants for full-arch fixed restorations: a preliminary study.

Peñarrocha-Diago MA, Maestre-Ferrín L, Demarchi CL, Peñarrocha-Oltra D, Peñarrocha-Diago M.

J Oral Maxillofac Surg. 2011 Jan;69(1):154-9. doi: 10.1016/j.joms.2010.07.083.

PMID:
21050641
18.

Immediate restoration of NobelActive implants placed into fresh extraction sites in the anterior maxilla.

Bell C, Bell RE.

J Oral Implantol. 2014 Aug;40(4):455-8. doi: 10.1563/AAID-JOI-D-11-00254.

PMID:
25106010
19.

Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

Ersan N, van Ruijven LJ, Bronckers AL, Olgaç V, Ilgüy D, Everts V.

Dentomaxillofac Radiol. 2014;43(1):20130144. doi: 10.1259/dmfr.20130144.

20.

Zoledronic acid: a review of its use in the treatment of osteoporosis.

Deeks ED, Perry CM.

Drugs Aging. 2008;25(11):963-86. doi: 10.2165/0002512-200825110-00007. Review.

PMID:
18947264

Supplemental Content

Support Center